Faculty

Cheryl Baker, PhD
University of Texas,
M.D. Anderson Cancer Center
 John Leonard, MD
Cornell University
Ronald Bukowski, MD
Cleveland Clinic
Steven K. Libutti, MD
National Cancer Institute
Michael Caligiuri, MD
Ohio State University School of Medicine
Brian Link, MD
University of Iowa
Peter Choyke, MD
National Institutes of Health,
Clinical Center
Lance Liotta, MD, PhD
National Cancer Institute
Benjamin G. Cocks, PhD
Incyte Genomics, Inc.
Michael Lotze, MD
University of Pittsburgh
Thomas Davis, MD
Medarex, Inc.
Marsha Moses, PhD
Harvard Medical School, Childrens Hospital
Theodore DeWeese, MD
Johns Hopkins Oncology Center
James Mulé, PhD
University of Michigan Medical Center
Robert O. Dillman, MD
Hoag Cancer Center
Michael O’Reilly, MD
University of Texas,
M.D. Anderson Cancer Center
Mary L. (Nora) Disis, MD
University of Washington
Karolina Palucka, MD, PhD
Baylor Institute for Immunology Research
Alexander Eggermont, MD, PhD
Rotterdam Cancer Institute
Juha Punnonen, MD, PhD
Maxygen, Inc.
Terry J. Fry, MD
National Cancer Institute,
Pediatric Oncology Branch
Joseph Rininger, PhD
CuraGen Corporation
Stanton Gerson, MD
Case Western Reserve University
Steven Rosenberg, MD, PhD
National Cancer Institute, Surgery Branch
Stephen Gillies, PhD
Lexigen Pharmaceuticals Corporation
Craig Slingluff, Jr., MD
University of Virginia Health Sciences Center
Jared Gollob, MD
Beth Israel Deaconess Medical Center
Paul Sondel, MD, PhD
University of Wisconsin
William Haseltine, PhD
Human Genome Sciences, Inc.
Walter Storkus, PhD
University of Pittsburgh School of Medicine
Stephen Hodi, MD
Dana-Farber Cancer Institute
David Weng, MD, PhD
Cleveland Clinic Foundation
Burkhard Jansen, MD
University of Vienna
Jon Wigginton, MD
Center for Cancer Research
National Cancer Institute
Javed Khan, MD
Advanced Technology Center
Jerry Zeldis, MD, PhD
Celgene Corporation
Arthur M. Krieg, MD
Coley Pharmaceutical Group
Robert Zimmerman, SD
Bayer Pharmaceutical Division